SPONSOR
Rocket Pharmaceuticals Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Rocket Pharmaceuticals Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM).
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Rocket Pharmaceuticals Inc.
How many clinical trials has Rocket Pharmaceuticals Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Rocket Pharmaceuticals Inc., of which 1 are actively recruiting participants. These trials cover conditions including PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rocket Pharmaceuticals Inc. research focus on?
Rocket Pharmaceuticals Inc. clinical trials span PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM). The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rocket Pharmaceuticals Inc. clinical trial?
To participate in a Rocket Pharmaceuticals Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rocket Pharmaceuticals Inc. trials with current recruitment status updated daily.
Clinical Trials by Rocket Pharmaceuticals Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology